Filing Flows › Cytek Biosciences (CTKB) › Product revenue
Cytek Biosciences (CTKB) Product revenue by quarter
Cytek Biosciences' Product revenue was $37.2M in Q3 2026 (third quarter 2026), +14% from Q2 2026. Over the last 7 quarters it ranged from $28.1M (Q1 2025) to $46.6M (Q4 2025).
| Quarter | Product revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $37.2M | +14% | -3% |
| Q2 2026 | $32.6M | +13% | +4% |
| Q1 2026 | $28.8M | -38% | +2% |
| Q4 2025 | $46.6M | +22% | — |
| Q3 2025 | $38.1M | +21% | — |
| Q2 2025 | $31.4M | +12% | — |
| Q1 2025 | $28.1M | — | — |
Q3 2026 at a glance
Cytek Biosciences, Q3 2026: revenue $53.2M (+2% year over year), operating margin -15.8%, net loss $6.1M, operating cash flow −$4.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cytek Biosciences' Product revenue?
Cytek Biosciences' Product revenue was $37.2M in Q3 2026 (third quarter 2026), +14% from Q2 2026.
How has Cytek Biosciences' Product revenue changed?
Over the last 7 quarters it ranged from $28.1M (Q1 2025) to $46.6M (Q4 2025).